Literature DB >> 10915908

Dopaminergic phenotype of hNT cells in vitro.

T Zigova1, L F Barroso, A E Willing, S Saporta, M P McGrogan, T B Freeman, P R Sanberg.   

Abstract

We investigated the catecholaminergic nature of cultured hNT neurons previously treated either for 4 or 5 weeks with retinoic acid (RA). There were significantly more tyrosine hydroxylase (TH)-positive neurons (60%) in cultures treated for 4 weeks with RA compared to 5 week-treated cultures (</=15%). Furthermore, numerous TH-positive hNT cells were also immunoreactive to dopamine transporter (DAT), dopamine receptor (D2) and aldehyde dehydrogenase (AHD-2), an enzyme exclusively expressed by dopaminergic (DA) ventral mesencephalic (VM) precursors. Thus this cell line has all the necessary cellular machinery to produce functional DA neurons and therefore is a good alternative tissue source to fetal VM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915908     DOI: 10.1016/s0165-3806(00)00055-9

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  9 in total

1.  PKCdelta alternatively spliced isoforms modulate cellular apoptosis in retinoic acid-induced differentiation of human NT2 cells and mouse embryonic stem cells.

Authors:  Niketa A Patel; Shijie S Song; Denise R Cooper
Journal:  Gene Expr       Date:  2006

2.  The role of connexins in the differentiation of NT2 cells in Sertoli-NT2 cell tissue constructs grown in the rotating wall bioreactor.

Authors:  R Shamekh; D F Cameron; A E Willing; S Saporta
Journal:  Exp Brain Res       Date:  2005-11-19       Impact factor: 1.972

Review 3.  Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.

Authors:  Yossef S Levy; Merav Stroomza; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 4.  Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.

Authors:  Connor Stonesifer; Sydney Corey; Shaila Ghanekar; Zachary Diamandis; Sandra A Acosta; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2017-07-23       Impact factor: 11.685

5.  Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo.

Authors:  Ming Yang; Angela E Donaldson; Cheryl E Marshall; James Shen; Lorraine Iacovitti
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

6.  Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation.

Authors:  Peter T Nelson; Douglas Kondziolka; Lawrence Wechsler; Steven Goldstein; James Gebel; Sharon DeCesare; Elaine M Elder; Paul J Zhang; Alan Jacobs; Michael McGrogan; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

7.  Novel cellular approaches to repair of neurodegenerative disease: from Sertoli cells to umbilical cord blood stem cells.

Authors:  Paul R Sanberg; Alison E Willing; David W Cahill
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

8.  The human testis-determining factor SRY localizes in midbrain dopamine neurons and regulates multiple components of catecholamine synthesis and metabolism.

Authors:  Daniel P Czech; Joohyung Lee; Helena Sim; Clare L Parish; Eric Vilain; Vincent R Harley
Journal:  J Neurochem       Date:  2012-06-08       Impact factor: 5.372

9.  Stem cell therapy for Parkinson's disease.

Authors:  Lars M Björklund
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.